These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 28598702)

  • 1. A safe and efficient BCG vectored vaccine to prevent the disease caused by the human Respiratory Syncytial Virus.
    Rey-Jurado E; Soto J; Gálvez N; Kalergis AM
    Hum Vaccin Immunother; 2017 Sep; 13(9):2092-2097. PubMed ID: 28598702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single, low dose of a cGMP recombinant BCG vaccine elicits protective T cell immunity against the human respiratory syncytial virus infection and prevents lung pathology in mice.
    Céspedes PF; Rey-Jurado E; Espinoza JA; Rivera CA; Canedo-Marroquín G; Bueno SM; Kalergis AM
    Vaccine; 2017 Feb; 35(5):757-766. PubMed ID: 28065474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired immune response to vaccination against infection with human respiratory syncytial virus at advanced age.
    Guichelaar T; Hoeboer J; Widjojoatmodjo MN; Reemers SS; van Els CA; Otten R; van Remmerden Y; Boes J; Luytjes W
    J Virol; 2014 Sep; 88(17):9744-50. PubMed ID: 24920795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human Respiratory Syncytial Virus: Role of Innate Immunity in Clearance and Disease Progression.
    Farrag MA; Almajhdi FN
    Viral Immunol; 2016; 29(1):11-26. PubMed ID: 26679242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV.
    Gálvez NMS; Soto JA; Kalergis AM
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28800119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.
    Díaz FE; Guerra-Maupome M; McDonald PO; Rivera-Pérez D; Kalergis AM; McGill JL
    Front Immunol; 2021; 12():664212. PubMed ID: 33981309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunopathology of RSV infection: prospects for developing vaccines without this complication.
    van Drunen Littel-van den Hurk S; Mapletoft JW; Arsic N; Kovacs-Nolan J
    Rev Med Virol; 2007; 17(1):5-34. PubMed ID: 17004293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological Features of Respiratory Syncytial Virus-Caused Pneumonia-Implications for Vaccine Design.
    Rey-Jurado E; Kalergis AM
    Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28273842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
    Taylor G; Thom M; Capone S; Pierantoni A; Guzman E; Herbert R; Scarselli E; Napolitano F; Giuliani A; Folgori A; Colloca S; Cortese R; Nicosia A; Vitelli A
    Sci Transl Med; 2015 Aug; 7(300):300ra127. PubMed ID: 26268314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency.
    Farrag MA; Amer HM; Öhlschläger P; Hamad ME; Almajhdi FN
    Hum Vaccin Immunother; 2017 Jul; 13(7):1586-1597. PubMed ID: 28272978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of mucosal and cellular immune response in mice by vaccination with respiratory syncytial virus DNA encapsulated with transfersome.
    Xu J; Ding Y; Yang Y
    Viral Immunol; 2008 Dec; 21(4):483-9. PubMed ID: 19115938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bovine model of respiratory syncytial virus infection.
    Taylor G
    Curr Top Microbiol Immunol; 2013; 372():327-45. PubMed ID: 24362697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel vaccine regimen elicits strong airway immune responses and control of respiratory syncytial virus in nonhuman primates.
    Grunwald T; Tenbusch M; Schulte R; Raue K; Wolf H; Hannaman D; de Swart RL; Uberla K; Stahl-Hennig C
    J Virol; 2014 Apr; 88(8):3997-4007. PubMed ID: 24453366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD8+ T cell immunity against human respiratory syncytial virus.
    Rossey I; Sedeyn K; De Baets S; Schepens B; Saelens X
    Vaccine; 2014 Oct; 32(46):6130-7. PubMed ID: 25223272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine.
    Tien Nguyen D; Boes J; van Amerongen G; van Remmerden Y; Yüksel S; Guichelaar T; Osterhaus AD; de Swart RL
    Hum Vaccin Immunother; 2013 Dec; 9(12):2578-83. PubMed ID: 23955280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of Host Immunity by Human Respiratory Syncytial Virus Virulence Factors: A Synergic Inhibition of Both Innate and Adaptive Immunity.
    Canedo-Marroquín G; Acevedo-Acevedo O; Rey-Jurado E; Saavedra JM; Lay MK; Bueno SM; Riedel CA; Kalergis AM
    Front Cell Infect Microbiol; 2017; 7():367. PubMed ID: 28861397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TCR Repertoire Characterization for T Cells Expanded in Response to hRSV Infection in Mice Immunized with a Recombinant BCG Vaccine.
    Rey-Jurado E; Bohmwald K; Correa HG; Kalergis AM
    Viruses; 2020 Feb; 12(2):. PubMed ID: 32093256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naked DNA immunization with full-length attachment gene of human respiratory syncytial virus induces safe and protective immune response.
    Hamad ME; Amer HM; Farrag MA; Osman AH; Almajhdi FN
    Acta Virol; 2018; 62(2):137-146. PubMed ID: 29895154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection and mechanism of action of a novel human respiratory syncytial virus vaccine candidate based on the extracellular domain of small hydrophobic protein.
    Schepens B; Sedeyn K; Vande Ginste L; De Baets S; Schotsaert M; Roose K; Houspie L; Van Ranst M; Gilbert B; van Rooijen N; Fiers W; Piedra P; Saelens X
    EMBO Mol Med; 2014 Nov; 6(11):1436-54. PubMed ID: 25298406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Respiratory syncytial virus: reverse genetics and vaccine strategies.
    Collins PL; Murphy BR
    Virology; 2002 May; 296(2):204-11. PubMed ID: 12069519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.